Section Arrow
Quote
KNSA.NASDAQ
- Kiniksa Pharmaceuticals International, plc
Quotes are at least 15-min delayed:2026/03/03 05:49 EST
Pre Market
Last
 46.31
+0.27 (+0.59%)
Bid
18.4
Ask
50
High 47 
Low 44 
Volume 4 
Regular Hours (Closed)
Last
 46
+1.51 (+3.39%)
Day High 
46.17 
Prev. Close
44.49 
1-M High
49.12 
Volume 
803.28K 
Bid
18.4
Ask
50
Day Low
43.51 
Open
44.13 
1-M Low
41.12 
Market Cap 
3.37B 
Currency 美元 
P/E 98.87 
%Yield -- 
10-SMA 45.27 
20-SMA 44.71 
50-SMA 42.96 
52-W High 49.12 
52-W Low 18.255 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
0.45/1.11
Enterprise Value
3.38B
Balance Sheet
Book Value Per Share
7.06
Cash Flow
Cash Flow Yield
0.03
Income Statement
Total Revenue
423.24M
Operating Revenue Per Share
3.28
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
HIMSHims & Hers Health16.48+1.96+13.50%28.59PE
Pre Market 15.71 -0.77 -4.67%
VTRSViatris15.7+0.79+5.30%-- 
Pre Market 15.5 -0.2 -1.27%
CGCCanopy Growth Corp1.07-0.06-5.31%-- 
Pre Market 1.07 -0.015 -1.38%
BHCBausch Health Companies5.95+0.02+0.34%14.12PE
Pre Market 5.92 -0.03 -0.50%
HLNHaleon plc10.87-0.2-1.81%24.58PE
Pre Market 10.51 -0.36 -3.31%
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and mavrilimumab.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.